127 reports of this reaction
2.8% of all AMMONIUM LACTATE reports
#3 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #3 most commonly reported adverse reaction for AMMONIUM LACTATE, manufactured by Padagis Israel Pharmaceuticals Ltd. There are 127 FDA adverse event reports linking AMMONIUM LACTATE to CHRONIC KIDNEY DISEASE. This represents approximately 2.8% of all 4,560 adverse event reports for this drug.
Patients taking AMMONIUM LACTATE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a less commonly reported adverse event for AMMONIUM LACTATE, but still significant enough to appear in the safety profile.
In addition to chronic kidney disease, the following adverse reactions have been reported for AMMONIUM LACTATE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 127 FDA reports for AMMONIUM LACTATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 2.8% of all adverse event reports for AMMONIUM LACTATE, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking AMMONIUM LACTATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.